Tulba, Sherwin O.

HRN: 23-82-88  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
CEFTRIAXONE 1G (VIAL)
10/06/2023
10/13/2023
IV
3gms
OD
Meningitic Dose; Brain Abscess
Waiting Final Action 
10/06/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/06/2023
10/13/2023
IV
750mg
TID
Brain Abscess
Waiting Final Action 
10/06/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/06/2023
10/12/2023
IVTT
4.5 G As LD
1 Dose
Brain Abscess
Waiting Final Action 
10/06/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/06/2023
10/12/2023
IVTT
2.25 G
Q8
Brain Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: